Thursday, November 20, 2025 at 2-3pm ET                           Pricing: Free for Members and Non-Members

Please note that this session is not accredited for continuing pharmacy education credit.

Program Description

This presentation highlights the burden of systemic lupus erythematosus (SLE) as a chronic, multisystem autoimmune disease with significant disparities in prevalence, outcomes, and access to care. It underscores the importance of early diagnosis and timely intervention to mitigate disease flares, prevent organ damage, and reduce long-term healthcare costs. The session focuses on advancing equitable healthcare approaches, fostering multidisciplinary care, and integrating patient-centered strategies to enhance outcomes across diverse populations.

Learning Objectives

• Recognize population-level disparities in SLE prevalence, outcomes, and access to specialty care.
• Identify modifiable risk factors for organ damage and strategies for early intervention.
• Understand the impact of corticosteroid use and the importance of minimizing long-term exposure.
• Gain the knowledge to facilitate the adoption of evidence-based guidelines for SLE management within healthcare systems and policy frameworks.

This webinar is sponsored, developed, and presented by the sponsor. The content of this Science & Innovation Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP.

Sponsored by:

PSE-US-4624 | November 2025

For individuals from the media/press interested in attending, please email media@amcp.org.